Optimal or standard control of systolic and diastolic blood pressure across risk factor categories in patients with chronic coronary syndromes

被引:1
作者
Vidal-Petiot, Emmanuelle [1 ,2 ,3 ]
Elbez, Yedid [4 ,5 ,6 ,7 ]
Mesnier, Jules [4 ,5 ,6 ]
Ducrocq, Gregory [4 ,5 ,6 ]
Ford, Ian [8 ]
Tendera, Michal [9 ]
Ferrari, Roberto [10 ,11 ]
Tardif, Jean-Claude [12 ]
Fox, Kim M. [13 ]
Steg, Philippe Gabriel [3 ,4 ,5 ,6 ]
机构
[1] Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Physiol Dept, 46 Rue Henri Huchard, F-75018 Paris, France
[2] Ctr Res Inflammat, INSERM U1149, 46 Rue Henri Huchard, F-75018 Paris, France
[3] Univ Paris Cite, UFR Medecine, Paris, France
[4] Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Cardiol Dept, 46 Rue Henri Huchard, F-75018 Paris, France
[5] FACT French Alliance Cardiovasc, 46 Rue Henri Huchard, F-75018 Paris, France
[6] Lab Vasc Translat Sci, INSERM U1148, 46 Rue Henri Huchard, F-75018 Paris, France
[7] Biostat Signifience, 35 Rue Oasis, F-92800 Puteaux La Defense, France
[8] Univ Glasgow, Robertson Ctr Biostat, Boyd Orr Bldg, Univ Ave, Glasgow G12 8QQ, Scotland
[9] Med Univ Silesia, Sch Med Katowice, Dept Cardiol & Struct Heart Dis, Ziolowa Str 45-47, PL-40635 Katowice, Poland
[10] Univ Ferrara, Ctr Cardiol Univ Ferrara, Via Aldo Moro 8, I-44124 Cona, FE, Italy
[11] Sci Dept Med Trial Anal MTA, Via Antonio Riva 6, CH-6900 Lugano, Switzerland
[12] Univ Montreal, Montreal Heart Inst, Dept Med, 5000 Belanger St, Montreal, PQ H1T 1C8, Canada
[13] Imperial Coll, Fac Med, NHLI, Dovehouse St, London SW3 6LP, England
关键词
CLARIFY registry; Chronic coronary syndromes; Hypertension; Blood pressure target; Risk factors; J-SHAPED CURVE; HYPERTENSIVE PATIENTS; CARDIOVASCULAR OUTCOMES; TASK-FORCE; MANAGEMENT; DISEASE; EVENTS; ATORVASTATIN; METAANALYSIS; GUIDELINES;
D O I
10.1093/eurjpc/zwad004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lay Summary We aimed to compare the benefit associated with strict vs. standard control of blood pressure with the potential benefit of controlling other modifiable risk factors in patients with chronic coronary syndromes (CCS).Our analysis conducted in nearly 20 000 patients from the CLARIFY registry (a prospective international cohort of patients with CCS) showed that the benefit associated with strict blood pressure (BP) control (BP < 130/80 mmHg) was marginal and only driven by the diastolic component of blood pressure, whereas having one or more uncontrolled other risk factors was associated with a gradually increasing risk, for all underlying BP levels.Patients with CCS should be treated to achieve BP <140/80 mmHg. However, our results suggest that optimizing the burden of other risk factors (lipid-lowering therapy, exercise, smoking cessation, diabetes control) may need to be prioritized before considering further reduction of systolic BP. Aims Guidelines have lowered blood pressure (BP) targets to <130/80 mmHg. We examined the benefit of intensive control for each BP component, vs. the burden of other modifiable risk factors, in patients with chronic coronary syndromes (CCS). Methods and results The CLARIFY registry (ISRCTN43070564) enrolled 32 703 patients with CCS, from 2009 to 2010, with a 5-year follow-up. Patients with either BP component below European guideline safety boundaries (120/70 mmHg) were excluded, leaving 19 167 patients (mean age: 63.8 +/- 10.1 years, 78% men) in the present analysis. A multivariable-adjusted Cox proportional hazards model showed a gradual increase in cardiovascular risk (cardiovascular death, myocardial infarction, or stroke) when the number of uncontrolled risk factors (active smoking, no physical activity, low-density lipoprotein cholesterol >= 100 mg/dL, and diabetes with glycated haemoglobin >= 7%) increased [adjusted hazard ratio (HR): 1.34; 95% confidence interval (CI): 1.17-1.52, 1.65 (1.40-1.94), and 2.47 (1.90-3.21) for 1, 2, and 3 or 4 uncontrolled risk factors, respectively, vs. 0], without significant interaction with BP. Although uncontrolled systolic (>= 140 mmHg) and diastolic (>= 90 mmHg) BP were both associated with higher risk than standard BP, standard BP was associated with higher risk than optimal control for only the diastolic component (adjusted HR: 1.08; 95% CI: 0.94-1.25 for systolic BP 130-139 vs. 120-129 mmHg and 1.43; 95% CI: 1.27-1.62 for diastolic BP 80-89 vs. 70-79 mmHg). Conclusions Our results suggest that the optimal BP target in CCS may be <= 139/79 mmHg and that optimizing the burden of other risk factors should be prioritized over the further reduction of systolic BP.
引用
收藏
页码:935 / 947
页数:13
相关论文
共 50 条
  • [1] A smartphone-guided secondary prevention digital health application reduces systolic blood pressure in patients with chronic coronary syndrome and insufficient blood pressure control
    Duesing, Philip
    Schirmer, Stephan H.
    Schaefer, Sebastian
    Krogmann, Alexander
    Sinning, Jan-Malte
    Werner, Nikos
    Boenner, Florian
    Sedaghat, Alexander
    Mueller, Cornelius
    Eckardt, Irina
    Nickenig, Georg
    Zietzer, Andreas
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2025, 12
  • [2] Systolic and Diastolic Blood Pressure Are Independent Risk Factors for Diabetic Retinopathy in Patients with Type 2 Diabetes
    Bulum, Tomislav
    Tomic, Martina
    Vrabec, Romano
    Brkljacic, Neva
    Ljubic, Spomenka
    BIOMEDICINES, 2023, 11 (08)
  • [3] Optimal systolic and diastolic blood pressure threshold that associated with lower risk of white matter hyperintensity progression
    Liu, Sibo
    Wang, Mengxing
    Gu, Dean
    Li, Yanzhao
    Zhang, Xin
    Li, Hang
    Ji, Chenhua
    Nie, Ximing
    Liu, Jinjie
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [4] Variability in systolic blood pressure - A risk factor for coronary heart disease?
    Grove, JS
    Reed, DM
    Yano, K
    Hwang, LJ
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1997, 145 (09) : 771 - 776
  • [5] Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials
    Boehm, Michael
    Schumacher, Helmut
    Teo, Koon K.
    Lonn, Eva
    Mahfoud, Felix
    Mann, Johannes F. E.
    Mancia, Giuseppe
    Redon, Josep
    Schmieder, Roland
    Weber, Michael
    Sliwa, Karen
    Williams, Bryan
    Yusuf, Salim
    EUROPEAN HEART JOURNAL, 2018, 39 (33) : 3105 - 3114
  • [6] Visit-to-visit variability in systolic blood pressure is a novel risk factor for the progression of coronary artery calcification
    Okada, Hiroshi
    Fukui, Michiaki
    Tanaka, Muhei
    Matsumoto, Shinobu
    Mineoka, Yusuke
    Nakanishi, Naoko
    Tomiyasu, Ki-ichiro
    Nakano, Koji
    Hasegawa, Goji
    Nakamura, Naoto
    HYPERTENSION RESEARCH, 2013, 36 (11) : 996 - 999
  • [7] Nifedipine GITS/Candesartan Combination Therapy Lowers Blood Pressure Across Different Baseline Systolic and Diastolic Blood Pressure Categories: DISTINCT Study Subanalyses
    Kjeldsen, Sverre E.
    Cha, Gloria
    Villa, Giuseppe
    Mancia, Giuseppe
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (09) : 1120 - 1129
  • [8] Blood pressure control and knowledge of target blood pressure in coronary patients across Europe: results from the EUROASPIRE III survey
    Prugger, Christof
    Keil, Ulrich
    Wellmann, Juergen
    de Bacquer, Dirk
    de Backer, Guy
    Ambrosio, Giovanni Battista
    Reiner, Zeljko
    Gaita, Dan
    Wood, David
    Kotseva, Kornelia
    Heidrich, Jan
    JOURNAL OF HYPERTENSION, 2011, 29 (08) : 1641 - 1648
  • [9] A cross sectional and longitudinal analysis of systolic and diastolic blood pressure control in diabetic patients
    Joseph, LA
    Castro, J
    Khorrami, S
    Sennimalai, G
    Gosukonda, P
    Deshmukh, M
    Arora, S
    Makaryus, J
    Casulo, C
    Lingam, D
    D'Angelo, S
    Mahmoud, M
    Shin, JJ
    Bahtiyar, G
    Farag, A
    Sowers, JR
    McFarlane, SI
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 47A - 47A
  • [10] Elevated Diastolic But Not Systolic Blood Pressure Increases Mortality Risk in Hypertensive But Not Normotensive Patients With Acute Ischemic Stroke
    Tziomalos, Konstantinos
    Giampatzis, Vasilios
    Bouziana, Stella D.
    Spanou, Marianna
    Papadopoulou, Maria
    Kostaki, Stavroula
    Dourliou, Vasiliki
    Papagianni, Marianthi
    Savopoulos, Christos
    Hatzitolios, Apostolos I.
    AMERICAN JOURNAL OF HYPERTENSION, 2015, 28 (06) : 765 - 771